Specialty drugs continue to be a concern for large employers, according to recently released survey data from the National Business Group on Health (NBGH). The Large Employers’ 2019 Health Care Strategy and Plan Design Survey, released Aug. 7, touched on issues within specialty drug management, including rebates and copay accumulator programs. Not surprisingly, employers would […]
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.